Skip to main content
Carol Aghajanian, MD, Oncology, New York, NY

CarolAAghajanianMD

Oncology New York, NY

Gynecologic Cancer

Chief, Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center

Overview of Dr. Aghajanian

Dr. Carol Aghajanian is the Chief of Gynecologic Medical Oncology at Memorial Sloan Kettering Cancer Center and Professor of Medicine, Weill Cornell Medical College, New York, NY.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1992 - 1995
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1989 - 1992
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 1989, MD, Cum Laude, Alpha Omega Alpha
  • Boston University
    Boston UniversityBA, Biology, Summa Cum Laude, Phi Beta Kappa, 1981 - 1985

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 1990 - 2026
  • NJ State Medical License
    NJ State Medical License 2019 - 2025
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2009-2014
  • America's Top Doctors for Cancer Castle Connolly, 2010-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Phase 1 Dose-Escalation Study of Intraperitoneal Cisplatin, intravenous/intraperitoneal Paclitaxel, Bevacizumab, and Olaparib for Newly Diagnosed Ovarian Cancer  
    Karen A Cadoo, Roisin E O'Cearbhaill, Dmitriy Zamarin, Paul J Sabbatini, William P Tew, Carol Aghajanian, Jason A Konner, Gynecologic Oncology
  • Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer  
    Kathleen Moore, Paul DiSilvestro, Carol Aghajanian, The New England Journal of Medicine

Lectures

  • Targeted Agents: Finding the Mark 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
  • Evaluation of rucaparib in platinum-sensitive recurrent ovarian carcinoma (rOC) in patients (pts) with or without residual bulky disease at baseline in the ARIEL3 study. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
  • Scientific and Clinical Update in Gynecologic Oncology 
    Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 5/3/2013

Press Mentions

  • Combination of Endometrial Cancer Drugs May Prolong Lives of Women
    Combination of Endometrial Cancer Drugs May Prolong Lives of WomenMarch 31st, 2023
  • Combining Immunotherapy with Chemo May Help Advanced Endometrial Cancer Patients Live Longer: Studies
    Combining Immunotherapy with Chemo May Help Advanced Endometrial Cancer Patients Live Longer: StudiesMarch 28th, 2023
  • New Drug Combo Buys More Time for Advanced Endometrial Cancer Patients
    New Drug Combo Buys More Time for Advanced Endometrial Cancer PatientsMarch 28th, 2023
  • Join now to see all

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment